Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC December Update

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Flecainide modified release 200mg capsules (Tambocor XL®) have been accepted for use in treating a variety of cardiac arrhythmias including AV nodal reciprocating tachycardia, Wolff-Parkinson-White Syndrome and atrial fibrillation in patients with disabling symptoms. It is also noted that the once-daily product has a lower acquisition cost than a twice-daily product at equivalent doses.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC December Update' on Email Share 'SMC December Update' on Delicious Share 'SMC December Update' on Digg Share 'SMC December Update' on Facebook Share 'SMC December Update' on Google+ Share 'SMC December Update' on reddit Share 'SMC December Update' on StumbleUpon Share 'SMC December Update' on Twitter

atomic-wealth

No Comments to “SMC December Update”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,518 spam comments.

atomic-wealth
fond-illness
summer